La Thérapie Genio® de Nyxoah Bénéficie d'une Augmentation Significative du Remboursement Medicare en 2026 en Vertu de la Règle Finale du CMS
Read more »
Posicionando Barbados como o polo de ciências da vida do Caribe
BRIDGETOWN, Barbados, Nov. 24, 2025 (GLOBE NEWSWIRE) — A Export Barbados (BIDC) e o EarlyHealth Group (EHG), com sede em Dubai, Emirados Árabes Unidos, assinaram uma Carta de Intenções para [...] Read more »
Barbados als Zentrum für Biowissenschaften in der Karibik positionieren
BRIDGETOWN, Barbados, Nov. 24, 2025 (GLOBE NEWSWIRE) — Export Barbados (BIDC) und die EarlyHealth Group (EHG) mit Hauptsitz in Dubai, Vereinigte Arabische Emirate, haben eine Absichtserklärung unterzeichnet, um [...] Read more »
La Barbade, vers un nouveau pôle des sciences de la vie dans les Caraïbes
BRIDGETOWN, Barbade, 24 nov. 2025 (GLOBE NEWSWIRE) — Export Barbados (BIDC) et EarlyHealth Group (EHG), dont le siège social est situé à Dubaï, aux Émirats arabes unis, ont [...] Read more »
Information on the total number of voting rights and shares
REGULATED INFORMATION
Information on the total number of voting rights and shares
Mont–Saint–Guibert [...] Read more »
Informations sur le nombre total de droits de vote et d'actions
INFORMATION RÉGLEMENTÉE
Informations sur le nombre total de droits de vote et d'actions
Mont–Saint–Guibert [...] Read more »
Positioning Barbados as the Caribbean’s Life Sciences Hub
BRIDGETOWN, Barbados, Nov. 14, 2025 (GLOBE NEWSWIRE) — Export Barbados (BIDC) and EarlyHealth Group (EHG), headquartered in Dubai, United Arab Emirates, have signed a Letter of Intent to jointly establish EarlyHealth [...] Read more »
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
INSIDE INFORMATION
REGULATED INFORMATION
Correction and Replacement
Nyxoah Secures Financing Commitments of up to U.S. $77 [...] Read more »
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
INSIDE INFORMATION
REGULATED INFORMATION
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
[...] Read more »Nyxoah Reports Third Quarter 2025 Financial and Operating Results
REGULATED INFORMATION
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
US launch off to a strong start. First commercial Genio [...] Read more »